Related Experiment Videos
Pericarditis: a rare complication of methotrexate therapy
Tayyab Mohyuddin1, Mazen Elyan1, Irving Kushner2
1MetroHealth Medical Center, 2500 MetroHealth Drive, Cleveland, OH, 44109, USA.
Abstract:
Serositis is a rare complication of methotrexate (MTX) administration. We report a 60-year-old man with rheumatoid arthritis who developed pericarditis after taking his weekly MTX dose, which recurred within hours after 2 subsequent weekly MTX doses. Pericarditis has not recurred after discontinuance of MTX over 3 years ago. We conclude that he had MTX-induced pericarditis, based on the close temporal relationship between MTX ingestion and manifestations of pericarditis on three distinct occasions because of the previous reports of MTX-induced pericarditis and because pericarditis has not recurred after MTX withdrawal.
Insights
Serositis, a rare methotrexate complication, can cause pericarditis. This case report details a rheumatoid arthritis patient who experienced recurrent pericarditis linked to methotrexate, resolving after drug discontinuation.
Area of Science:
- Rheumatology
- Clinical Medicine
- Pharmacology
Background:
- Methotrexate (MTX) is a common disease-modifying antirheumatic drug (DMARD) used for rheumatoid arthritis.
- Serositis, including pericarditis, is a rare but recognized complication of MTX therapy.
Observation:
- A 60-year-old male patient with rheumatoid arthritis developed acute pericarditis shortly after weekly MTX administration.
- The pericarditis recurred within hours following two subsequent weekly MTX doses.
- Pericarditis symptoms completely resolved after MTX was discontinued and did not recur over a three-year follow-up period.
Findings:
- The temporal association between MTX dosing and pericarditis onset, recurrence, and resolution strongly suggests MTX-induced pericarditis.
- This case aligns with previous literature reporting MTX-associated serositis.
Implications:
- Clinicians should consider MTX-induced pericarditis in rheumatoid arthritis patients presenting with pleuritic chest pain or pericarditis symptoms.
- Discontinuation of MTX should be strongly considered in cases of suspected MTX-induced pericarditis.
- This case underscores the importance of vigilant monitoring for rare adverse drug reactions during long-term MTX therapy.
Related Concept Videos
Pericarditis III: Medical Management
Pericarditis I: Introduction
Myocarditis III: Medical Management
Pericarditis II: Clinical Features and Diagnostic Tests
Pericarditis IV: Nursing Management
Myocarditis I: Introduction